< Back to previous page
Researcher
An Goris
- Disciplines:Immunology
Affiliations
- Laboratory for Neuroimmunology (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Apr 2004 → 31 Dec 2011 - Immunobiology (Rega Institute) (Lab)
Member
From1 Oct 1999 → 31 Mar 2004
Projects
11 - 20 of 42
- Inter-individual variation in susceptibility to and disease course of multiple sclerosisFrom1 Oct 2020 → 20 Apr 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Early miccoglial biomarkers for long-term progression in multiple sclerosis.From15 Aug 2020 → 9 Aug 2022Funding: Foundations, funds and other with scientific goal
- Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the ImmunomeFrom1 Jan 2020 → TodayFunding: H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture, marine and maritime research and the bio-economy, H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Molecular determinants of regulatory T cell lineage identity and fate lossFrom1 Oct 2019 → 1 Oct 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization of regulatory B-cell subsets emerging in multiple sclerosis treatmentFrom1 Jan 2019 → 31 Dec 2020Funding: Foundations, funds and other with scientific goal
- Somatic mutations leading to CD8+ T cell proliferation contribute to the pathogenesis of multiple sclerosisFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- Somatic mutations leading to CD8+T cell proliferation contribute to the pathogenesis of multiple sclerosisFrom1 Aug 2018 → 31 Jul 2022Funding: Foundations, funds and other with scientific goal
- The role of glial cells in sALS and C9orf72 HRE-mediated ALSFrom1 Aug 2018 → 20 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- The genetic basis for relapse rate in multiple sclerosisFrom26 Jul 2018 → 25 Jul 2020Funding: Foundations, funds and other with scientific goal
- Mass cytometry by time-of-flight: next-generation flow cytometry for multiplexed single cell analysisFrom1 May 2018 → 30 Apr 2022Funding: FWO Medium Size Research Infrastructure
Publications
1 - 10 of 111
- A targeted sequencing extension for transcript genotyping in single-cell transcriptomics(2023)
Authors: Margaux David, An Goris, Bénédicte Dubois
- Exploring genetic clustering of severity markers to identify groups with reduced heterogeneity in multiple sclerosis(2023)
Authors: An Goris
Pages: 479 - 480 - The role of glial cells in sALS and C9orf72 HRE-mediated ALS(2023)
Authors: Pegah Masrori, Philip Van Damme, An Goris
- Locus for severity implicates CNS resilience in progression of multiple sclerosis(2023)
Authors: Bénédicte Dubois, An Goris
Pages: 329 - 331 - Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198.(2023)
Authors: Jeroen Blommaert, Charlotte Sleurs, Sigrid Hatse, An Goris, Michel Koole, Ann Smeets, Koen Van Laere, Stefan Sunaert, Sabine Deprez
Pages: 3091 - Genetics of multiple sclerosis: lessons from polygenicity(2022)
Authors: An Goris
Pages: 830 - 842 - Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies(2022)
Authors: Marijne Vandebergh, Bénédicte Dubois, An Goris
Pages: 4565 - 4574 - Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study(2022)
Authors: Marijne Vandebergh, Bénédicte Dubois, An Goris
- From susceptibility to heterogeneity in multiple sclerosis: insights from genetic epidemiology(2022)
Authors: Marijne Vandebergh, An Goris, Bénédicte Dubois
- Natural killer cells in multiple sclerosis: entering the stage.(2022)
Authors: Jarne Beliën, An Goris, Patrick Matthys